Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Xeris Biopharma Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- +39 vs. Q4 2024
- Shares held
- 87.6M
- +23.9M (+37.6%) vs. Q4 2024
- Total value
- $480.9M
- +$265.1M (+122.9%) vs. Q4 2024
- New holders
- 57
- 72 more added
- Sold out
- 18
- 39 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XERS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $857.1M |
| Q1 2026 | 239 | $610.3M |
| Q4 2025 | 227 | $792.0M |
| Q3 2025 | 231 | $789.3M |
| Q2 2025 | 201 | $422.9M |
| Q1 2025 | 199 | $480.9M |
| Q4 2024 | 162 | $222.2M |
| Q3 2024 | 144 | $182.2M |
| Q2 2024 | 135 | $136.6M |
| Q1 2024 | 142 | $133.7M |
| Q4 2023 | 120 | $140.8M |
| Q3 2023 | 111 | $102.3M |
| Q2 2023 | 105 | $146.7M |
| Q1 2023 | 92 | $80.6M |
| Q4 2022 | 97 | $71.6M |
| Q3 2022 | 101 | $89.3M |
| Q2 2022 | 103 | $91.3M |
| Q1 2022 | 103 | $129.2M |
| Q4 2021 | 92 | $120.2M |
| Q3 2021 | 71 | $42.9M |
| Q2 2021 | 94 | $114.9M |
| Q1 2021 | 103 | $149.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Xeris Biopharma Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caxton Corp | 0 | $0 | 0.00% | −2,015,157−100.0% | Sold out |
| Fairfax Financial Holdings LtdSuperinvestorFairfax Financial | 0 | $0 | 0.00% | −139,687−100.0% | Sold out |
| Rossby Financial, LCC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −25,200−100.0% | Sold out |
| Powell Investment Advisors, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Savant Capital, LLC | 0 | $0 | 0.00% | −22,116−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −20,910−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,137−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −14,684−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −10,536−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −3,294−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| BFSG, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −1,632−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −847−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |